Wednesday, 8 April 2020

Kidney Stone Management Devices Market is Poised to Reach at a CAGR of 4.3% by 2025


Overview:
The kidney stone market is creating quite a ripple owing to the technological advancements it has seen over the years. This advancement has made treatments more impactful, and the permeation of healthcare has eased the integration process of the kidney stone sector across social strata, inflating the market in the process. The medicinal and engineering leaps the industry has taken in over the decades made the diagnosis easier and treatment more reliable. The global kidney stone management market is expecting a growth of 4.6% CAGR during the forecast period (2019-2025), reveals Market Research Future (MRFR). Their published report has its focus on segmental analysis, and factors that can impact the market in the foreseeable future. Among the major factors, increasing adoption of the industry-based life and approval of urban ways have squarely inspired a spurt in cases related to urolithiasis. In addition, diabetes and kidney stone are diseases that grow in tandem, and diabetes is one of the most prevalent diseases in the world which gives a glimpse of possibilities for the kidney stone market in the coming years. At the same time, minimally invasive surgeries are becoming a trend and they are cost-effective which makes people rely on it more than before.
On the downside, extracorporeal shock wave lithotripsy can cause hypertension deterring the kidney stone market prospect during the forecast period. But a long slumber cannot be expected as other therapies can steer the kidney stone market out of any further damage.
Segmental Analysis
The market segmentation of the kidney stone market comprises of types of test, treatment types, diagnosis options, and regions. By types of tests, the kidney stone market comprises of cystine stones, uric acid, struvite kidney stones, and calcium stones. The segmentation on the basis of treatment types comprises of ureteroscopy (URS), extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), and medications. The diagnosis options-based segmentation of the kidney stone market comprises of X-ray, intravenous pyelography (IVP) or intravenous urogram, computed tomography (CT) scan, and ultrasound. The regional segments included in the market are Europe, North America, Asia Pacific, and the Middle East and Africa.
Detailed Regional Analysis 
The regional analysis of the kidney stone market comprises of Europe, North America, Asia Pacific, and the Middle East and Africa. The North American region is presently leading the global market portion. The European region has the second place in the market. The Asia Pacific region has gained the third spot and is projected to display considerable growth due to the incidence of countries such as China, India, and Japan. China is leading the region as it is in the top most contributing position. Though, the contribution from the MEA and the LATAM are the minimum as their healthcare sector is still undergoing a substantial overhauling transformation.
Competitive Analysis
The market has prominently nullified the market trials and thus is encouraging a boost in the number of companies in the market. The market is at the topmost production level and will be able to make better value for the firms in the market and its shareholders. The ability to utilize the economies of scale is proving to be positive for the market’s complete growth. The diversification of the product variety in the market is raising the prospects for the advancement of the market. The organization inclination in the market is reinforcing the level of expansion that can be achieved in the current market scenario.  The development patterns are modified in tandem to the customer penchant to realize the maximum growth, and in the long run, viability.
The top competitors in the kidney stone market are DirexGroup (Israel), Boston Scientific Corp. (U.S.), Stryker Corp. (U.S.), Medispec Ltd. (U.S.), Convergent Laser Technologies (U.S.), Storz Medical AG (Switzerland), C.R. Bard Inc. (U.S.), E.M.S. Electro Medical Systems S.A. (Switzerland), Cook Medical Inc. (U.S.), Elmed Electronics & Medical Industry & Trade Inc. (Turkey), Siemens Ltd. (Germany), Olympus Corp. (Japan), Richard Wolf GmbH (Germany), and others.
Industry Updates:
July 2018 The National Institute for Health and Care Excellence has published a new draft for guidelines calling for the quicker treatment of patients with kidney stones feeling severe pain. The Institute is backing wider admission to a procedure named shockwave lithotripsy (SWL), which beams soundwaves into the kidneys from outside the body to destroy the stones, without the need for traditional surgery. According to the recommendations, the eligible individuals should be offered the procedure within 48-hours of medical assessment.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.



Update: Healthcare Contract Manufacturing Market booming with highest CAGR Value 9.8% by 2023

Overview:
The healthcare contract manufacturing market is benefiting much from the growing demand for medicine supplies which is facing a severe crisis from the pending expiration of a lot of generic drugs. The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers. From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides. The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR). The report ensures a detailed analysis of the segments and driving factors that can assist the market in growth over the review period. 
Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the market growth during the forecast period. Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion. Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up. Factors such as these are bound to boost the global from drug development to drug manufacturing market.
On the flip side, controlling third parties is quite complex which many manufacturers prefer to avoid. At the same time, clinical trials are becoming more exhaustive and tangled which can deter the healthcare contract manufacturing market from having the expected growth rate over the review period.
Segmentation:
The global healthcare contract manufacturing market can be segmented by type, service type, and industry.
Based on the type, the healthcare contract manufacturing market can be segmented into sterile and non-sterile.
On the basis of the service type, the healthcare contract manufacturing market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.
Industry-wise segmentation of the healthcare contract manufacturing market includes pharmaceutical, medical device, and biopharmaceutical.
Regional Analysis:
Region-specific analysis of the global healthcare contract manufacturing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas is in charge of the global healthcare contract manufacturing market. With rising investment in healthcare, the focus is mainly on improving healthcare infrastructure and upgrading research institutions for better technology and others. Subsequently, manufacturers are now relying more on the advanced instruments they have put in use in their factories and manufacturing capabilities. 
Europe assumes the second position in the market and the credit goes to the increased expenditure initiated by the regional governments. The reports published by the Organization for Economic Co-operation and Development (OECD) discloses that Germany spent USD 321 billion in 2014 in the healthcare sector which is a significant marker of the progress the regional market is making at present. 
The APAC is the fastest growing market as major regional economies such as China and India are considerably investing to better their healthcare facilities to lure in patients from all over the world as a part of their medical tourism planning.
Competitive Analysis:
Some of the key players in this healthcare contract manufacturing market are Aesica Pharmaceuticals, Boehringer Ingelheim, AbbVie, Grifols International, S.A, Evonik Industries, Lonza Ag, Catalent, Benchmark Electronics, Flex Ltd, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Teva Pharmaceutical Industries, Patheon, Mylan, Vetter Pharma International, and others.
In August 2018, Catalent completed their move to acquire Juniper. This would give the former a new and robust European base to function. Catalent, as the parent company of Juniper, would ensure the supply of Crinone marketed by Merck KGaA. 
In January 2018, Intermountain Healthcare declared their plan to create a non-profit generic drug company as a direct manufacturer or contract manufacturer in collaboration with Ascension, SSM Health, and Trinity Health. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Updates: Homeopathic Market Size, Share Investment and Development Trends

Market Insight
Homeopathic medicines have grown in numbers, especially in healthcare and medicine sector. Market reports related to healthcare and medicine industry have been revealed by Market Research Future that states that the global homeopathic market is anticipated to observe an unprecedented growth at 12.5% CAGR, during the forecast period by 2023. The development of alternative medicine, the homeopathy, introduced in 1976, is used in treatments with the help of natural sources such as plants, animals and chemicals or minerals. 
The market for homeopathy has expanded remarkably because of the increasing demand for natural remedies. Growing prevalence of chronic and lifestyle-related diseases such as obesity, diabetes, cancer, and fertility issues have led to a faster adoption of alternative medical treatments such as homeopathic medicine. However, the market is regulated by strict laws pertaining to the application of homeopathy in some developed nations like the U.K. and Germany. Meanwhile, many developing economies pose a high possibility for development attributing to the cultural propinquity for natural medication.
Key Drivers
The fact that homeopathy is gradually being accepted as an all-inclusive form of treatment, fuels its growth globally. Homeopathy covers most of the facets of a person's health and the cost is comparatively lower than other conventional or mainstream medicines. Practitioners of homeopathy go through the activity level and biological age of their patients, before planning a line of treatment. This provides them with reasonable duration for deciding the frequency of medication. As a result, it is often seen as a safe option by the users. Also, homeopathy has lesser side effects.

Market Segmentation

The global homeopathic market has also mentioned some of the segments on which it is dependent and has the maximum share of the market. The segments are type, indication, and end-users. 
By type: This includes plants based and animal based and mineral. Wherein, plant-based is further segmented into Arnica montana, Bryonia alba, Cinchona officinalis, Pulsatilla nigricans, Rhus tox, Symphytum. Also, animal-based is further segmented into Latrodectus mactans, Tarentula Hispania, Tarentula cubensis, Naja tripudians, Vipera, Sepia, and Cantharis. The mineral is further segmented into Calcarea carbonica, Phosphorus, Calcarea phosphorica, Natrum muriaticuma, and others. Other segments are Nosodes, Sarcodes, and Imponderabilia.
By application: This includes skin & hair, reproductive health, lifestyle disorders, bones, joints, and muscles diseases, brain and nerves disorders, respiratory diseases, childhood diseases, hormonal disorders, and others.
By end-user: This includes hospitals, homeopathic clinics, and others.
Regional Analysis
North America is a key market for homeopathic medicine attributing to the growing awareness about homeopathic treatment coupled with the increasing usage of homeopathic medicine. As a result, homeopathy has a significant presence in the U.S. healthcare sector.
Europe represents the second largest market on account of the rising number of homeopathy professionals and the growing inclination among users towards natural treatments. UK has been reported as the primary market for homeopathic medicine in Europe. As per the Commission of European Communities, 100 million European Union (EU) population (29% of the EU’s population) relies on homeopathic treatment. 
Asia Pacific witnesses an increasing demand for alternative medicine such as ayurveda and homeopathy owing to the rising incidence of chronic illnesses such as obesity and diabetes. Additionally, the amplifying demand of medicines made from natural sources fuels the market growth. India is the prime market for homeopathy in Asia Pacific on account of its key homeopathic set-up and rise in the number of homeopathic research centers and medical institutes. Furthermore, Japanese Homoeopathic Medical Association is involved in the international exchange of homoeopathy, promotion, and academic research in Japan. However, homeopathy is comparatively unfamiliar and moderately practiced in China.
Over the last few years, the MEA has observed exponential rise in disposable income which has increased the number of customers for the homeopathy market. Saudi Arabia and Iran are the nations where homeopathy is widely practiced in comparison to other countries in the Middle East. 
Key Players
The noteworthy players in the global homeopathic medicine market include names such as Natural Health Supply (U.S.), Hahnemann Laboratories Inc. (U.S.), Boiron USA (U.S), SBL (India), HomeoLab USA (Canada), Nelson & Co. Ltd. (U.K), and Hyland’s Homeopathic (U.S.)
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

What’s Driving the Artificial Kidney Market | Top Players in the Current Competition are: Kawasumi Laboratories, Blood Purification Technologies, AWAK Technologies Pte, Triomed AB

Global Artificial Kidney Market Research Report: By Type (Wearable Artificial Kidney, Implantable Artificial Kidney) and Dialysis (Hemodialysis, Peritoneal Dialysis, Combination) - Forecast till 2025

Industry Overview 
 The global artificial kidney market size is likely to touch USD 2,795.01 million at a 95.54% CAGR between 2019-2025, as per the latest Market Research Future (MRFR) report. An artificial kidney or hemodialyzer helps to filter the blood of an individual having kidney damage. It offers the advantage of constant blood filtration. An artificial kidney can help in reducing kidney disease and improve the patient’s quality of life. These devices are lightweight and rely on batteries that are long-lasting, highly permeable membranes, new filtering materials, and advances in miniaturization. 
A bioartificial kidney is in great demand for the plentiful benefits that it offers. These surgically implanted devices are small and compact and come with human kidney cells and a filtration unit that is highly permeable. As they have live cells, they can filter the blood theoretically and also at the same time, perform vital functions of the real kidney, such as help to release hormones for controlling blood pressure. 
Numerous factors are adding to the global artificial kidney market growth. Such factors, according to the MRFR report, include rising prevalence of kidney disease, minimum/less availability of kidney donors, an increase in kidney transplant surgeries, rising disposable income, and advanced healthcare facilities. Additional factors adding to global artificial kidney market growth include favorable reimbursement policies, increasing investments by key players for technological advances, research, and development activities to develop cost-effective products, and emphasis by the government to develop healthcare infrastructure. 
Market Segmentation
The MRFR report provides an inclusive segmental analysis of the global artificial kidney market based on dialysis and type. 
By type, the global artificial kidney market is segmented into the implantable artificial kidney and wearable artificial kidney. Of these, the wearable artificial kidney will lead the market over the forecast period for the technical benefits of artificial organs and the increasing prevalence of renal failure. 
By dialysis, the global artificial kidney market is segmented into peritoneal dialysis, haemodialysis, and combination. Of these, haemodialysis will have a major share in the market over the forecast period for the increasing number of haemodialysis procedures. 

Regional Analysis
By region, the global artificial kidney market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period for the rising prevalence of chronic kidney diseases, rising R&D by public and private organizations, and the presence of top market players in the region. 
The global artificial kidney market in Europe is predicted to hold the second-largest share over the forecast period for the growing geriatric population coupled with technological advances in medicine and technology. 
The global artificial kidney market in the APAC region is predicted to grow at a quick pace over the forecast period for increasing opportunities for industry players for investing in the region, rising investments by government bodies, increasing disposable income, and increasing incidence of renal failure. 

The global artificial kidney market in the MEA is likely to have a small share during the forecast period. However, increasing awareness about the benefits of artificial kidney among patients and untapped markets may boost the market growth in the upcoming years. 
 Key Players
 Notable players profiled in the global artificial kidney market report include Asahi Kasei Medical Vo., Ltd, Triomed AB. (Sweden), AWAK Technologies Pte.Ltd.(Singapore), Blood Purification Technologies Inc., and Kawasumi Laboratories, Inc. (Japan). 
 Industry News 
December 2019: Researchers at the US Kidney Research Corporation have developed an artificial kidney that can help to purify blood for creating its own urine. This approach, unlike dialysis, do not need dialysate or purified water, which adds expense and complexity for patients and providers. 

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Monday, 6 April 2020

Ligation Devices Market Trends- Industry Demand and Forecast to 2024


Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024

The global ligation devices market trends is expected to register a CAGR of 6.7% during the forecast period of 2019 to 2024.
Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.
Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.
Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.
Regional Analysis
The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.
In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.
On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
…..
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Global Analysis On Diabetes Monitors Market 2020

Diabetes monitors market Insights 
Rapid urbanization, a growing geriatric population, changing lifestyles and a prevalence of unbalanced diets have contributed to the increasing occurrence of type 2 diabetes in the global population. This has inevitably created a more widespread demand for diabetes monitors. Both type 1 and 2 diabetes are widespread across the globe, with type 2 being the more commonly occurring form of diabetes of the two. According to the International Diabetes Federation 1 in 11 adults (425 millions) has diabetes and over two-thirds of these cases are recorded in urban areas. While, there is no cure for the disease, it can be managed through ongoing monitoring, the demand for appropriate diabetic monitoring technologies has incited considerable growth and will continue to do so as the market develops during the forecast period.
Market Research Future (MRFR) has published a comprehensive market report that identifies trends and restraints that affect growth. The report also identifies market opportunities based on extensive analysis of the diabetes monitors market. MRFR has revealed that the global market is estimated to reach a value of USD $17.4 billion by 2023 and experience a CAGR of 8.3% during the forecast period (2017 - 2023). 
The global diabetes monitors market is projected to witness considerable growth during the forecast period, this is due to the huge research and development investment in advancing treatment options and providing monitoring solutions that are semi to non-invasive. Governments and other regulatory bodies worldwide, are encouraging innovative relevant technologies for diabetes monitoring. Although high costs associated with diagnosis & treatment and the inconvenience associated with common monitoring devices (finger pricking) are expected to hamper market growth, the demand for efficient and affordable monitoring methods is likely to propel growth as innovation progresses.
Market Segmentation
Segmental analysis of the global diabetes monitors market has been based on sample, type, component and end-users.
Based on sample, the market has been segmented into blood samples, urine samples, sweat samples and others. Blood samples are the largest market segment and is expected to possess a 75.70% share and witness a CAGR of 8.6% during the forecast period of 2017 to 2023. 
Based on type, the market has been segmented into point sample test based glucose monitors, continuous glucose monitors and enzyme free sensor based glucose monitors. Continuous glucose monitors (CGM) have been further sub-segmented to include, disposable sensor based CGM and re-usable sensor based CGM
Based on components, the market has been classified into lancet, glucose test strips and sensors. Sensors have been sub-segmented into enzyme based sensors and enzyme free sensors.
Based on end users, the market has been segmented into diagnostic clinics, hospitals and home.

Regional Analysis
The Americas possess the largest global market share owing to the strong presence of leading market players, large investments in research & development, a well-developed health sector and a large patient population in the region. The high prevalence of diabetes in this area has prompted government and private organizations to actively encourage improvement of treatment options available. 
Europe holds the second largest global market share and like the Americas, this region has supportive government associations that drive research and development to improve existing monitoring technologies. The strong potential for viable treatment and monitoring innovations from this region are fueling market growth. 
Asia Pacific is predicted to be the fastest growing global market segment. Countries such as India and China count amongst countries with the highest occurrence of diabetes, the presence of a colossal patient population in the region is driving substantial growth for the region. There is a strong requirement for affordable monitoring devices and other relevant diabetes care which is attracting major players to cater to this region.
The Middle East and Africa includes countries such as the U.A.E., Qatar and Kuwait where an immensely rapid urbanization has led to a high number of diabetes diagnoses, thus driving growth for this market. However, due to the presence of impoverished and under developed economies of many African countries in this region is expected to limit growth during the forecast period.
Key Players
MRFR’s report analyzes the strategies of major players that participate in the competitive landscape of this market so as to provide relevant insights. Key players included in the report are LifeScan Inc., Panasonic, Dexcom Inc., Abbot Laboratories, F.Hoffmann La-Roche Ltd., Medtronic and Sanofi.  
Latest Industry News
Dexcom has announced Food and Drug Administration (FDA) approval of the Dexcom G6 CGM System. The device is developed to be used as a standalone CGM and for integration into automated insulin dosing (AID) devices. Perhaps the most impressive feature about this system is that it eliminated the need for finger sticks and is non-invasive. The sensor is also developed for longer use and will last 43% longer than previous version of the device.
Researchers at the UC San Diego Jacobs School of Engineering led by UC San Diego Centre for Wearable Sensors director and co-director have developed a glucose monitoring patch that is non-invasive. The patch is applied onto the skin like a temporary children's tattoo and contains electrodes that apply a minuscule electric current which forces molecules of glucose to rise to the surface for measurement. This monitoring method has enrolled for clinical trials. The method is expected to potentially be a viable non-invasive, user friendly and affordable monitoring solution.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com


Biological Stains Market Trends 2020 is Expected to Surge with 7.1%CAGR by 2023, Covering Major Applications, Product types, Key players, Focused Regions, Forecasting

Global Biological Stains Market: Information by Type (Acid Fuchsin, Congo Red, Eosin, and Others), Application (Histology, Bacteriology, Protein Staining, Gram Staining, and Others), End-User (Diagnostic Laboratories and Others)–Global Forecast Till 2023
Biological Stains Market Highlights
Staining is a supplementary technique used to enhance the contrast in the microscopic image.  Biological stains are essential in the identification of physical, chemical and structural characteristics of biological content. The increasing use of stains in healthcare and life sciences research, the surge in the number of infectious diseases and increasing commercial use of stains are the factors responsible for the growth of the biological stains market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, and merger and acquisition activities are contributing to the growth of the market. For instance, in January 2017, Bio-Rad Laboratories announced the acquisition of RainDance Technologies for approximately USD  87 million. RainDance Technologies offers products such as microdroplet solutions for the early detection of cancer and other diseases.
The high costs associated with biological stains, availability of substitutes and risk of contamination due to the use of biological stains are likely to hinder the market growth during the forecast period.
Global Biological Stains Market, by Region
Americas
  • North America
  • US
  • Canada
  • South America
Europe
  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Rest of Western Europe
  • Eastern Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
Middle East & Africa
  • Middle East
  • Africa
Segmentation
The global biological stains market trends has been segmented on the basis of type, application, and end-user.
On the basis of type, the market has been classified as acid fuchsin, Congo red, crystal violet, eosin, methylene blue, iodine, safranin, and others. The eosin segment has been further divided into eosin Y, alcoholic eosin Y, eosin B, eosin- phloxine, and picro-eosin. The application segment has been further divided into histology, bacteriology, protein staining, gram staining, protein staining, DNA staining, and fluorescence microscopy.
The market, by end-user, has been segmented into diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, and others.
Key Players
Some of the key players in the global biological stains market are Thermo Fisher Scientific Inc., Avantor, Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Water Corporation, and bioMérieux SA.
 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312